GlassScriptPhysician profile
Amir B Behnam
NPI 1447215678
$937.78
in general payments reported to CMS, 2019-2025
10 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $286 · 2021: $137 · 2022: $22.89 · 2023: $57.97 · 2024: $18.38 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $255.55 | 2020-2021 | |
| Polarityte, INC. | $169.08 | 2019-2020 | |
| Allergan, INC. | $134.74 | 2019 | |
| Bsn Medical INC | $118.39 | 2025 | |
| Biocomposites INC | $83.06 | 2025 | Stimulan |
| Mentor Worldwide LLC | $76.24 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $39.52 | 2019-2022 | |
| Lifenet Health | $36.27 | 2023 | |
| Axogen | $16.99 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $7.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Behnam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.